Department of Biochemistry and Biotechnology, University of Thessaly, 26 Ploutonos Str., 41221 Larissa, Greece.
ChemMedChem. 2012 Apr;7(4):722-32. doi: 10.1002/cmdc.201100533. Epub 2012 Jan 20.
C5 halogen substituted glucopyranosyl nucleosides (1-(β-D-glucopyranosyl)-5-X-uracil; X=Cl, Br, I) have been discovered as some of the most potent active site inhibitors of glycogen phosphorylase (GP), with respective K(i) values of 1.02, 3.27, and 1.94 μM. The ability of the halogen atom to form intermolecular electrostatic interactions through the σ-hole phenomenon rather than through steric effects alone forms the structural basis of their improved inhibitory potential relative to the unsubstituted 1-(β-D-glucopyranosyl)uracil (K(i) =12.39 μM), as revealed by X-ray crystallography and modeling calculations exploiting quantum mechanics methods. Good agreement was obtained between kinetics results and relative binding affinities calculated by QM/MM-PBSA methodology for various substitutions at C5. Ex vivo experiments demonstrated that the most potent derivative (X=Cl) toward purified GP has no cytotoxicity and moderate inhibitory potency at the cellular level. In accordance, ADMET property predictions were performed, and suggest decreased polar surface areas as a potential means of improving activity in the cell.
C5 卤素取代的吡喃葡萄糖核苷(1-(β-D-吡喃葡萄糖基)-5-X-尿嘧啶;X=Cl、Br、I)已被发现是糖原磷酸化酶(GP)最有效的活性位点抑制剂之一,其相应的 K(i) 值分别为 1.02、3.27 和 1.94 μM。通过 X 射线晶体学和利用量子力学方法进行的建模计算揭示,卤素原子通过 σ 空穴现象而不是仅通过空间位阻形成分子间静电相互作用的能力,构成了它们相对于未取代的 1-(β-D-吡喃葡萄糖基)尿嘧啶(K(i)=12.39 μM)的抑制潜力提高的结构基础。对于 C5 上的各种取代,通过 QM/MM-PBSA 方法进行的动力学研究结果与相对结合亲和力的计算之间得到了很好的一致性。在体外实验中,证明对纯化的 GP 具有最强抑制活性的衍生物(X=Cl)没有细胞毒性,在细胞水平上具有适度的抑制活性。因此,进行了 ADMET 性质预测,表明减少极性表面积可能是提高细胞内活性的一种潜在手段。